CVS · 8-K · 20261104PR446150

Strategic Business Separation

CVS HEALTH Corp · 2026-11-04 · Importance 58 · Surprise 42

On November 4, 2026, CVS Health announced plans to separate into two publicly traded companies: a healthcare solutions company comprising Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health, and CVS Pharmacy, comprising approximately 9,000 pharmacies, mail pharmacy, MinuteClinic and Health100. The separation is expected to be completed in the first half of 2028 and is intended to be tax-free to CVS Health and its shareholders for U.S. federal income tax purposes, subject to customary conditions including board approval, SEC Form 10 effectiveness and confirmation of the tax treatment. At separation, both companies are expected to have solid investment-grade ratings, strong free cash flow, balance-sheet capacity and attractive dividends, with independent capital structures to support tailored capital allocation. CVS Health said the separation will allow each company to focus its strategy and adapt more nimbly to regulatory and other external dynamics.

Key facts

• On November 4, 2026, CVS Health announced its intent to separate into two independent, publicly traded companies. source
• The separation is expected to be completed in the first half of 2028. source
• The planned healthcare solutions company will comprise Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health. source
• The planned CVS Pharmacy company will comprise approximately 9,000 CVS pharmacies, mail pharmacy, MinuteClinic (including virtual care), and the Health100 technology services business. source
• Upon separation, current CVS Health Chairman and CEO David Joyner will be Chairman and CEO of the healthcare solutions company. source
• Upon separation, current CVS Health Group President Prem Shah will be CEO of CVS Pharmacy. source
• The separation is intended to be structured as tax-free to CVS Health and its shareholders for U.S. federal income tax purposes. source
• Completion of the separation is subject to customary conditions, including final approval by the CVS Health Board of Directors, effectiveness of a Form 10 registration statement filed with the SEC, and customary confirmation of tax-free treatment. source